ArticleOncotarget2018

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.

Marta Cabezón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.